| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | CEO and President
1 company
Lisa A Conte is See Remarks at JAGX. Lisa A Conte's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $16K at current prices.
Net of sales, the JAGX filings show accumulation of 9,468 shares.
Lisa A Conte has 23 Form 4 filings on record from June 2016 to December 2025, all as Jaguar Health (JAGX), 2016–2025.
The 37 reported transactions were 21 option or other derivative awards, 6 option exercises, 5 open-market purchases and 3 stock awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 2 purchases worth about $22K and no sales.
The largest open-market purchase was 7,968 shares of JAGX at an average $2.51 on September 13, 2021, about $20K. Twelve months later JAGX was down 90%.